Pitfalls of “hyper”-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature

被引:0
作者
A. Heinold
B. Hanebeck
V. Daniel
J. Heyder
T. H. Tran
B. Döhler
J. Greil
F.-M. Müller
机构
[1] University of Heidelberg,Department of Transplantation Immunology, Institute of Immunology, University Hospital for Pediatric and Adolescent Medicine
[2] University of Heidelberg,Department of General Pediatrics, University Hospital for Pediatric and Adolescent Medicine
[3] University of Heidelberg,Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, University Hospital for Pediatric and Adolescent Medicine
[4] University of Heidelberg,Pediatric Pulmonology and Infectious Diseases, III
来源
Infection | 2010年 / 38卷
关键词
Immunodeficiency; Hyper-IgM; CD40 ligand; Mutation;
D O I
暂无
中图分类号
学科分类号
摘要
Here, we report on a male infant with low serum IgG, IgA and IgM levels who suffered from Pneumocystis jirovecii and cytomegalovirus (CMV) pneumonia. The patient was tested to be HIV-negative. Absolute and relative numbers of lymphocyte subsets were normal, excluding the diagnosis of an X-linked agammaglobulinaemia (Bruton’s disease). Despite the decreased serum IgM level, an X-linked hyper-IgM syndrome (X-HIGM) was considered. X-HIGM is a rare immunodeficiency usually characterised by recurrent severe opportunistic infections, low serum IgG and IgA, but normal or increased serum IgM. The syndrome is caused by mutations of the CD40 ligand (CD40L) gene. In our patient, CD40L mutation analysis proved a novel mutation at codon 257 associated with non-detectable expression of CD40L on the surface of activated T cells. A literature search revealed that approximately 6.4% of X-HIGM patients had been found to have low serum IgM levels. Our statistical analysis of the IgM levels as reported by different studies arouses suspicion that many patients with low IgM levels may not have undergone diagnostic procedures for X-HIGM. In summary, in this report and critical review of the literature, we described a new mutation of CD40L and highlighted the pitfalls of the diagnosis of X-HIGM.
引用
收藏
页码:491 / 496
页数:5
相关论文
共 293 条
[1]  
Fuleihan RL(2001)Hyper IgM syndrome: the other side of the coin Curr Opin Pediatr 13 528-532
[2]  
Levy J(1997)Clinical spectrum of X-linked hyper-IgM syndrome J Pediatr 131 47-54
[3]  
Espanol-Boren T(1997)A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency Clin Exp Immunol 107 230-234
[4]  
Thomas C(1993)CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome Science 259 990-993
[5]  
Fischer A(1993)The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome Cell 72 291-300
[6]  
Tovo P(1993)CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM Nature 361 541-543
[7]  
Bordigoni P(1993)Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM Nature 361 539-541
[8]  
Resnick I(1994)Defective expression of CD40 ligand on T cells causes “X-linked immunodeficiency with hyper-IgM (HIGM1)” Immunol Rev 138 39-59
[9]  
Fasth A(2002)Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation Biochem Soc Trans 30 815-818
[10]  
Baer M(1992)Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes Eur J Immunol 22 2573-2578